## **Core Concept**
Carisoprodol is a prodrug that is metabolized in the liver to its active metabolite. It acts as a centrally acting muscle relaxant. The primary mechanism of action involves modulation of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA).

## **Why the Correct Answer is Right**
The correct answer, , is a metabolite of Carisoprodol because it is formed through the cytochrome P450 enzyme system in the liver. Specifically, Carisoprodol is metabolized to meprobamate, which is an active metabolite that contributes to its therapeutic and side effects profile. Meprobamate has anxiolytic and sedative properties.

## **Why Each Wrong Option is Incorrect**
- **Option A:** - This option is incorrect because it does not accurately represent a known metabolite of Carisoprodol.
- **Option B:** - This option is incorrect as it is not identified as a metabolite of Carisoprodol.
- **Option D:** - This option is incorrect because it is not a recognized metabolite of Carisoprodol.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that Carisoprodol is metabolized to meprobamate, which has a potential for abuse and is a controlled substance in some jurisdictions. This is crucial for clinicians when prescribing Carisoprodol, especially for patients with a history of substance abuse.

## **Correct Answer:** .